Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

CGM

EASD 2025 Preview: Key Diabetes Highlihts to Watch

EASD 2025 at a glance In the lead-up to EASD 2025, LucidQuest spotlights…

Endocrinology

Endocrinology Weekly Update - July 15th 2025

🧬 Endocrinology Update: Stem Cell T1D Breakthrough, Smart Glucose Wearable,…

ADA_2025_Preview_by_LucidQuest

ADA 2025 Preview: Diabetes Care Highlights to Watch

ADA at a glance Identify the most relevant presentations and…

Endocrinology

Endocrinology Weekly Update - May 20th 2025

🧬 Endocrinology Update: Mounjaro, Cell Therapy, Diabetes Tech & More From…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Hematology Today—February 16, 2026
Oncology Video Recap—February 16, 2026
Oncology Today—February 16, 2026
Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal
Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL

Tags

Alzheimers Research antifungals Biopharma Marketing Bispecifics Blood Pressure calcification-resistant tissue Capsida Biotherapeutics CD19/CD20 Cirtuvivint Competitive Intelligence Software content analytics COPD research CORE-MD CRSwNP Eye Health finerenone genomic medicine HCC IgG4RD IL-23 receptor Insulin Pump Long COVID Lunit INSIGHT Lyme Disease menopause mHSPC Mitochondrial Disease NRF2 NS Pharma OSA osteoporosis care p47CGD Patent litigation PD-L1 inhibitor Pila Pharma Polpharma Biologics Reblozyl seltorexant Sleep Technology T-cell lymphoma Thyroid Artery Embolization VK2735 Youth Health Zeposia Zoryve

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Hematology Today—February 16, 2026
Oncology Video Recap—February 16, 2026
Oncology Today—February 16, 2026
Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal
Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL

TAGS

Alzheimers Research antifungals Biopharma Marketing Bispecifics Blood Pressure calcification-resistant tissue Capsida Biotherapeutics CD19/CD20 Cirtuvivint Competitive Intelligence Software content analytics COPD research CORE-MD CRSwNP Eye Health finerenone genomic medicine HCC IgG4RD IL-23 receptor Insulin Pump Long COVID Lunit INSIGHT Lyme Disease menopause mHSPC Mitochondrial Disease NRF2 NS Pharma OSA osteoporosis care p47CGD Patent litigation PD-L1 inhibitor Pila Pharma Polpharma Biologics Reblozyl seltorexant Sleep Technology T-cell lymphoma Thyroid Artery Embolization VK2735 Youth Health Zeposia Zoryve

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy